biotech products / nondigital and digital media / media platforms / communications platforms / pharmaceutical industry / media vehicles / communications vehicle carrying / Internet advertising / social media guidance / social and digital media development / media outlets / past communications vehicles / digital communications / social media vehicles / social media platforms / pharmaceutical / healthcare / social media assets / social media circles / social media platform / pharmaceutical and biologic medicines / communications efforts / social media / healthcare communications / Online report / healthcare professionals / search tools / medical products / promotional communications / drug advertising / prescription products / digital healthcare / digital and social media / digital media vehicles / digital media / biologic products / pharmaceutical product promotion / pharmaceutical and other medical products / expanded Web-based properties / communications vehicles / industry communications / healthcare providers / social media use / drug products / healthcare information / /
MedicalCondition
disease / /
Organization
Division of Drug Marketing / Advertising / and Communications / FDA’s OPDP / U.S. Food and Drug Administration / FDA / FDA’s office of Prescription Drug Promotion / /
Person
Mark S. Senak / Investigational Drug / Susannah Fox / /
FDA COMMUNICATIONS Oversight